| Name | Title | Contact Details |
|---|
Wayne Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Wayne Memorial Hospital is based in Goldsboro, NC. You can find more information on Wayne Memorial Hospital at www.waynehealth.org
Hialeah Hospital is a 378-bed acute care facility with an experienced medical staff of more than 900 employees. Since we first opened our doors in 1951, we have provided compassionate care to our neighbors and their friends and families. Because we know hospital trips are especially challenging for our elderly neighbors, we provide specially designed senior services including a Senior ER and an Acute Care for the Elderly (ACE) Unit.
Founded in 1947, Hill Top Research is one of the world's leading clinical research services companies with research centers throughout North America. Hill Top Research provides services including clinical research, microbiology, and CRO services for the
Assisted Living *Skilled Nursing* Short-term rehab* The Benedictine Health System is one of the largest Catholic senior living organizations in the country, operating more than 35 communities in five states. BHS is a mission-based, non-profit health system headquartered in Minnesota, sponsored by the Benedictine Sisters of St. Scholastica Monastery in Duluth. BHS provides complete senior living and care services for aging adults, including independent housing, assisted living, long-term skilled nursing care, short-term rehabilitation and memory care. Mission The Benedictine Health System is a Catholic, faith-based organization entrusted with advancing the life-enhancing senior care ministry of the Benedictine Sisters of Duluth, Minnesota. We witness to God`s love by creating compassionate communities providing support to those we serve to live fully and live well with special concern for the underserved and those in need. Vision Creating Benedictine Living Communities where health, wellness and choice come to life.
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.